CARD11 is a prognostic biomarker and correlated with immune infiltrates in uveal melanoma.
Uveal melanoma (UVM), the most common primary intraocular malignancy, has a high mortality because of a high propensity to metastasize. Our study analyzed prognostic value and immune-related characteristics of CARD11 in UVM, hoping to provide a potential management and research direction. The RNA-se...
Guardado en:
Autores principales: | Xueying Shi, Shilin Xia, Yingming Chu, Nan Yang, Jingyuan Zheng, Qianyi Chen, Zeng Fen, Yuankuan Jiang, Shifeng Fang, Jingrong Lin |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b466d864045d41ea9bb9fb66b2ab48ba |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Blood Biomarkers of Uveal Melanoma: Current Perspectives
por: Bande Rodríguez MF, et al.
Publicado: (2020) -
Prognostic Values of G-Protein Mutations in Metastatic Uveal Melanoma
por: Mizue Terai, et al.
Publicado: (2021) -
BAP1 methylation: a prognostic marker of uveal melanoma metastasis
por: Mathieu F. Bakhoum, et al.
Publicado: (2021) -
Uveal Melanoma Metastasis
por: Ernesto Rossi, et al.
Publicado: (2021) -
A novel prognostic biomarker LCP2 correlates with metastatic melanoma-infiltrating CD8+ T cells
por: Zijun Wang, et al.
Publicado: (2021)